Plasmacytoid dendritic cells and autoimmune inflammation

Biological Chemistry

Volumn 395, Issue 3, 2014, Pages 335-346

  Galicia, Georgina ^a   Gommerman, Jennifer L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dendritic cells (DC); Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis (MS); Type I interferon (type I IFN)

Indexed keywords

3 [2 (3 TRIFLUOROMETHYL 4 BIPHENYLYL)BENZO[B]THIEN 5 YLMETHYLAMINO]PROPIONIC ACID; BETA INTERFERON; CHEMOKINE RECEPTOR CCR7; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B KINASE ALPHA; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17F; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MYELIN; MYELOID DIFFERENTIATION FACTOR 88; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NUCLEIC ACID; PADGEM PROTEIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ADOPTIVE TRANSFER; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; CELL TRANSFER; CHRONIC INFLAMMATION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG TARGETING; EFFECTOR CELL; ENDOPLASMIC RETICULUM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOID PROGENITOR CELL; MACROPHAGE; MULTIPLE SCLEROSIS; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; ONTOGENY; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH17 CELL; VIRUS INFECTION; ANIMAL; CYTOLOGY; DENDRITIC CELL; IMMUNOLOGY;

ANIMALIA;

ANIMALS; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; INFLAMMATION;

EID: 84902139532     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0213     Document Type: Review

References (96)

1. Allman, D., Dalod, M., Asselin-Paturel, C., Delale, T., Robbins, S.H., Trinchieri, G., Biron, C.A., Kastner, P., and Chan, S. (2006). Ikaros is required for plasmacytoid dendritic cell differentiation. Blood 108, 4025-4034.
2. Andersen, O., Lygner, P.E., Bergstrom, T., Andersson, M., and Vahlne, A. (1993). Viral infections trigger multiple sclerosis relapses: A prospective seroepidemiological study. J. Neurol. 240, 417-422.
3. Aung, L.L., Fitzgerald-Bocarsly, P., Dhib-Jalbut, S., and Balashov, K. (2010). Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferonbeta. J. Neuroimmunol. 226, 158-164.
4. Axtell, R.C., de Jong, B.A., Boniface, K., van der Voort, L.F., Bhat, R., De Sarno, P., Naves, R., Han, M., Zhong, F., Castellanos, J.G., et al. (2010). T helper type 1 and 17 cells determine efficacy of interferon-â in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16, 406-412.
5. Bailey, S.L., Schreiner, B., McMahon, E.J., and Miller, S.D. (2007). CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8, 172-180.
6. Bailey-Bucktrout, S.L., Caulkins, S.C., Goings, G., Fischer, J.A., Dzionek, A., and Miller, S.D. (2008). Cutting edge: Central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 180, 6457-6461.
7. Balashov, K.E., Aung, L.L., Vaknin-Dembinsky, A., Dhib-Jalbut, S., and Weiner, H.L. (2010). Interferon-â inhibits toll-like receptor 9 processing in multiple sclerosis. Ann. Neurol. 68, 899-906.
8. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.J., Pulendran, B., and Palucka, K. (2000). Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
9. Bao, M., and Liu, Y.J. (2013). Regulation of TLR7/9 signaling in plasmacytoid dendritic cells. Protein Cell 4, 40-52.
10. Baxter, A.G. (2007). The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7, 904-912.
11. Bayas, A., Stasiolek, M., Kruse, N., Toyka, K.V., Selmaj, K., and Gold, R. (2009). Altered innate immune response of plasmacytoid dendritic cells in multiple sclerosis. Clin. Exp. Immunol. 157. 332-342.
12. Cao W. Bover L. (2010). Signaling and ligand interaction of ILT7: Receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol. Rev. 234, 163-176.
13. Carotta, S., Dakic, A., D'Amico, A., Pang, S.H., Greig, K.T., Nutt, S.L., and Wu, L. (2010). The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner. Immunity 32, 628-641.
14. Cella, M., Facchetti, F., Lanzavecchia, A., and Colonna, M. (2000). Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1, 305-310.
15. Cella, M., Jarrossay, D., Facchetti, F., Alebardi, O., Nakajima, H., Lanzavecchia, A., and Colonna, M. (1999). Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 5, 919-923.
16. Chiurchiu, V., Cencioni, M.T., Bisicchia, E., De Bardi, M., Gasperini, C., Borsellino, G., Centonze, D., Battistini, L., and Maccarrone, M. (2013). Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis. Ann Neurol. 73, 626-636.
17. Cisse, B., Caton, M.L., Lehner, M., Maeda, T., Scheu, S., Locksley, R., Holmberg, D., Zweier, C., den Hollander, N.S., Kant, S.G., et al. (2008). Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 135, 37-48.
18. Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., Carson, W.E., and Caligiuri, M.A. (2001). Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset. Blood 97, 3146-3151.
19. Crozat, K., Guiton, R., Guilliams, M., Henri, S., Baranek, T., Schwartz-Cornil, I., Malissen, B., and Dalod, M. (2010). Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol. Rev. 234, 177-198.
20. Dai, J., Megjugorac, N.J., Amrute, S.B., and Fitzgerald-Bocarsly, P. (2004). Regulation of IFN regulatory factor-7 and IFN-α production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J. Immunol. 173, 1535-1548.
21. Deal, E.M., Lahl, K., Narvaez, C.F., Butcher, E.C., and Greenberg, H.B. (2013). Plasmacytoid dendritic cells promote rotavirusinduced human and murine B cell responses. J. Clin. Invest. 123, 2464-2474.
22. Derkow, K., Bauer, J.M., Hecker, M., Paap, B.K., Thamilarasan, M., Koczan, D., Schott, E., Deuschle, K., Bellmann-Strobl, J., Paul, F., et al. (2013). Multiple sclerosis: Modulation of toll-like receptor (TLR) expression by interferon-â includes upregulation of TLR7 in plasmacytoid dendritic cells. PLoS One 8, e70626.
23. Di Pucchio, T., Chatterjee, B., Smed-Sorensen, A., Clayton, S., Palazzo, A., Montes, M., Xue, Y., Mellman, I., Banchereau, J., and Connolly, J.E. (2008). Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9, 551-557.
24. Diacovo, T.G., Blasius, A.L., Mak, T.W., Cella, M., and Colonna, M. (2005). Adhesive mechanisms governing interferon-producing cell recruitment into lymph nodes. J. Exp. Med. 202, 687-696.
25. Domingues, H.S., Mues, M., Lassmann, H., Wekerle, H., and Krishnamoorthy, G. (2010). Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One 5, e15531.
26. Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D.W., and Schmitz, J. (2000). BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037-6046.
27. Eidenschenk, C., Crozat, K., Krebs, P., Arens, R., Popkin, D., Arnold, C.N., Blasius, A.L., Benedict, C.A., Moresco, E.M., Xia, Y., et al. (2010). Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells. Proc. Natl. Acad. Sci. USA 107, 9759-9764.
28. Facchetti, F., de Wolf-Peeters, C., Mason, D.Y., Pulford, K., van den Oord, J.J., and Desmet, V.J. (1988). Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/ macrophage origin. Am. J. Pathol. 133, 15-21.
29. Feng, X., Reder, N.P., Yanamandala, M., Hill, A., Franek, B.S., Niewold, T.B., Reder, A.T., and Javed, A. (2012). Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis. J. Neurol. Sci. 313, 48-53.
30. Fonteneau, J.F., Larsson, M., Beignon, A.S., McKenna, K., Dasilva, I., Amara, A., Liu, Y.J., Lifson, J.D., Littman, D.R., and Bhardwaj, N. (2004). Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells. J. Virol. 78, 5223-5232.
31. Fuchs, A., Cella, M., Kondo, T., and Colonna, M. (2005). Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood. 106, 2076-2082.
32. Galicia-Rosas, G., Pikor, N., Schwartz, J.A., Rojas, O., Jian, A., Summers-Deluca, L., Ostrowski, M., Nuesslein-Hildesheim, B., and Gommerman, J.L. (2012). A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner. J. Immunol. 189, 3700-3706.
33. Gao, Y., Majchrzak-Kita, B., Fish, E.N., and Gommerman, J.L. (2009). Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-beta. Blood 114, 2623-2631.
34. Gay, N.J., Gangloff, M., and O'Neill, L.A. (2011). What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol. 32, 104-109.
35. Georg, P. and Bekeredjian-Ding, I. (2012). Plasmacytoid dendritic cells control B cell-derived IL-10 production. Autoimmunity 45, 579-583.
36. Gilliet, M., Cao, W., and Liu, Y.J. (2008). Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594-606.
37. Goubier, A., Dubois, B., Gheit, H., Joubert, G., Villard-Truc, F., Asselin-Paturel, C., Trinchieri, G., and Kaiserlian, D. (2008). Plasmacytoid dendritic cells mediate oral tolerance. Immunity 29, 464-475.
38. Haas, J., Fritzsching, B., Trubswetter, P., Korporal, M., Milkova, L., Fritz, B., Vobis, D., Krammer, P.H., Suri-Payer, E., and Wildemann, B. (2007). Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J. Immunol. 179, 1322-1330.
39. Heyder, P., Bekeredjian-Ding, I., Parcina, M., Blank, N., Ho, A.D., Herrmann, M., Lorenz, H.M., Heeg, K., and Schiller, M. (2007). Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-α. Autoimmunity 40, 331-332.
40. Irla, M., Kupfer, N., Suter, T., Lissilaa, R., Benkhoucha, M., Skupsky, J., Lalive, P.H., Fontana, A., Reith, W., and Hugues, S. (2010). MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207, 1891-1905.
41. Isaksson, M., Ardesjo, B., Ronnblom, L., Kampe, O., Lassmann, H., Eloranta, M.L., and Lobell, A. (2009). Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Eur. J. Immunol. 39. 2925-2935
42. Jego, G., Palucka, A.K., Blanck, J.P., Chalouni, C., Pascual, V., and Banchereau, J. (2003). Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225-234.
43. Ji, Q., Castelli, L., and Goverman, J.M. (2013). MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8+ T cells. Nat. Immunol. 14, 254-261.
44. Kalinke, U. and Prinz, M. (2012). Endogenous, or therapeutically induced, type I interferon responses differentially modulate Th1/Th17-mediated autoimmunity in the CNS. Immunol. Cell. Biol. 90, 505-509.
45. Kool, M., Geurtsvankessel, C., Muskens, F., Madeira, F.B., van Nimwegen, M., Kuipers, H., Thielemans, K., Hoogsteden, H.C., Hammad, H., and Lambrecht, B.N. (2011). Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigenpresenting potential of plasmacytoid DCs. J. Leukoc. Biol. 90, 1177-1190.
46. Kornete, M. and Piccirillo, C.A. (2012). Functional crosstalk between dendritic cells and Foxp3+ regulatory T cells in the maintenance of immune tolerance. Front. Immunol. 3, 165.
47. Korporal, M., Haas, J., Balint, B., Fritzsching, B., Schwarz, A., Moeller, S., Fritz, B., Suri-Payer, E., and Wildemann, B. (2008). Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells. Arch. Neurol. 65, 1434-1439.
48. Lande, R., Gafa, V., Serafini, B., Giacomini, E., Visconti, A., Remoli, M.E., Severa, M., Parmentier, M., Ristori, G., Salvetti, M., et al. (2008). Plasmacytoid dendritic cells in multiple sclerosis: Intracerebral recruitment and impaired maturation in response to interferon-â. J. Neuropathol. Exp. Neurol. 67, 388-401.
49. Lande, R. and Gilliet, M. (2010). Plasmacytoid dendritic cells: Key players in the initiation and regulation of immune responses. Ann. N.Y. Acad. Sci. 1183, 89-103.
50. Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F., and Tough, D.F. (2001). Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 1, 461-470.
51. Le Bon, A., Thompson, C., Kamphuis, E., Durand, V., Rossmann, C., Kalinke, U., and Tough, D.F. (2006). Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. 176, 2074-2078.
52. Li, Z., Lim, W.K., Mahesh, S.P., Liu, B., and Nussenblatt, R.B. (2005). Cutting edge: In vivo blockade of human IL-2 receptor induces expansion of CD56(bright) regulatory NK cells in patients with active uveitis. J. Immunol. 174, 5187-5191.
53. Limmroth, V., Putzki, N., and Kachuck, N.J. (2011). The interferon beta therapies for treatment of relapsing-remitting multiple sclerosis: Are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination. Ther. Adv. Neurol. Disord. 4, 281-296.
54. Longhini, A.L., von Glehn, F., Brandao, C.O., de Paula, R.F., Pradella, F., Moraes, A.S., Farias, A.S., Oliveira, E.C., Quispe-Cabanillas, J.G., Abreu, C.H., et al. (2011). Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse. J. Neuroinflammation 8, 2.
55. Lopez, C., Comabella, M., Al-zayat, H., Tintore, M., and Montalban, X. (2006). Altered maturation of circulating dendritic cells in primary progressive MS patients. J. Neuroimmunol. 175, 183-191.
56. Loschko, J., Heink, S., Hackl, D., Dudziak, D., Reindl, W., Korn, T., and Krug, A.B. (2011). Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity. J. Immunol. 187, 6346-6356.
57. Merad, M., Sathe, P., Helft, J., Miller, J., and Mortha, A. (2013). The dendritic cell lineage: Ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604.
58. Mitosek-Szewczyk, K., Tabarkiewicz, J., Wilczynska, B., Lobejko, K., Berbecki, J., Nastaj, M., Dworzanska, E., Kolodziejczyk, B., Stelmasiak, Z., and Rolinski, J. (2013). Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis. J. Neurol. Sci. 332, 35-40.
59. Moore, A.J. and Anderson, M.K. (2013). Dendritic cell development: A choose-your-own-adventure story. Adv. Hematol. 2013, 949513.
60. Mouries, J., Moron, G., Schlecht, G., Escriou, N., Dadaglio, G., and Leclerc, C. (2008). Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112, 3713-3722.
61. Naves, R., Singh, S.P., Cashman, K.S., Rowse, A.L., Axtell, R.C., Steinman, L., Mountz, J.D., Steele, C., De Sarno, P., and Raman, C. (2013). The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 191, 2967-2977.
62. Obermoser, G. and Pascual, V. (2010). The interferon-Á signature of systemic lupus erythematosus. Lupus 19, 1012-1019.
63. Ogata, M., Ito, T., Shimamoto, K., Nakanishi, T., Satsutani, N., Miyamoto, R., and Nomura, S. (2013). Plasmacytoid dendritic cells have a cytokine-producing capacity to enhance ICOS ligand-mediated IL-10 production during T-cell priming. Int. Immunol. 25, 171-182.
64. Okada, T., Ngo, V.N., Ekland, E.H., Forster, R., Lipp, M., Littman, D.R., and Cyster, J.G. (2002). Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 196, 65-75.
65. Onai, N., Kurabayashi, K., Hosoi-Amaike, M., Toyama-Sorimachi, N., Matsushima, K., Inaba, K., and Ohteki, T. (2013). A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential. Immunity 38, 943-957.
66. Pashenkov, M., Huang, Y.M., Kostulas, V., Haglund, M., Soderstrom, M., and Link, H. (2001). Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 124, 480-492.
67. Prinz, M., Schmidt, H., Mildner, A., Knobeloch, K.P., Hanisch, U.K., Raasch, J., Merkler, D., Detje, C., Gutcher, I., Mages, J., et al. (2008). Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28, 675-686.
68. Sanna, A., Huang, Y.M., Arru, G., Fois, M.L., Link, H., Rosati, G., and Sotgiu, S. (2008). Multiple sclerosis: Reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. Mult Scler. 14, 1199-1207.
69. Saraste, M., Irjala, H., and Airas, L. (2007). Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-â. Neurol. Sci. 28, 121-126.
70. Sasaki, I., Hoshino, K., Sugiyama, T., Yamazaki, C., Yano, T., Iizuka, A., Hemmi, H., Tanaka, T., Saito, M., Sugiyama, M., et al. (2012). Spi-B is critical for plasmacytoid dendritic cell function and development. Blood 120, 4733-4743.
71. Sathe, P., Vremec, D., Wu, L., Corcoran, L., and Shortman, K. (2013). Convergent differentiation: Myeloid and lymphoid pathways to murine plasmacytoid dendritic cells. Blood 121, 11-19.
72. Satpathy, A.T., Kc, W., Albring, J.C., Edelson, B.T., Kretzer, N.M., Bhattacharya, D., Murphy, T.L., and Murphy, K.M. (2012a). Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209, 1135-1152.
73. Satpathy, A.T., Wu, X., Albring, J.C., and Murphy, K.M. (2012b). Re(de)fining the dendritic cell lineage. Nat. Immunol. 13, 1145-1154.
74. Schotte, R., Nagasawa, M., Weijer, K., Spits, H., and Blom, B. (2004). The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J. Exp. Med. 200, 1503-1509.
75. Schwab, N., Zozulya, A.L., Kieseier, B.C., Toyka, K.V., and Wiendl, H. (2010). An imbalance of two functionally and phenotypically different subsets of plasmacytoid dendritic cells characterizes the dysfunctional immune regulation in multiple sclerosis. J. Immunol. 184, 5368-5374.
76. Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., Capello, E., Mancardi, G.L., and Aloisi, F. (2006). Dendritic cells in multiple sclerosis lesions: Maturation stage, myelin uptake, and interaction with proliferating T cells. J. Neuropathol. Exp. Neurol. 65, 124-141.
77. Seth, S., Oberdorfer, L., Hyde, R., Hoff, K., Thies, V., Worbs, T., Schmitz, S., and Forster, R. (2011). CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J. Immunol. 186, 3364-3372.
78. Shigematsu, H., Reizis, B., Iwasaki, H., Mizuno, S., Hu, D., Traver, D., Leder, P., Sakaguchi, N., and Akashi, K. (2004). Plasmacytoid dendritic cells activate lymphoid-specific genetic programs irrespective of their cellular origin. Immunity 21, 43-53.
79. Shiow, L.R., Rosen, D.B., Brdickova, N., Xu, Y., An, J., Lanier, L.L., Cyster, J.G., and Matloubian, M. (2006). CD69 acts downstream of interferon-Á/â to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440, 540-544.
80. Siegal, F.P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P.A., Shah, K., Ho, S., Antonenko, S., and Liu, Y.J. (1999). The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837.
81. Sospedra, M. and Martin, R. (2005). Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747.
82. Sozzani, S., Vermi, W., Del Prete, A., and Facchetti, F. (2010). Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 31, 270-277.
83. Stasiolek, M., Bayas, A., Kruse, N., Wieczarkowiecz, A., Toyka, K.V., Gold, R., and Selmaj, K. (2006). Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 129, 1293-1305.
84. Teige, I., Treschow, A., Teige, A., Mattsson, R., Navikas, V., Leanderson, T., Holmdahl, R., and Issazadeh-Navikas, S. (2003). IFN-α gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170, 4776-4784.
85. Tezuka, H., Abe, Y., Asano, J., Sato, T., Liu, J., Iwata, M., and Ohteki, T. (2011). Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity. 34, 247-257.
86. Tumanov, A.V., Koroleva, E.P., Guo, X., Wang, Y., Kruglov, A., Nedospasov, S., and Fu, Y.X. (2011). Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 10, 44-53.
87. Venken, K., Hellings, N., Hensen, K., Rummens, J.L., Medaer, R., D'Hooghe M, B., Dubois, B., Raus, J., and Stinissen, P. (2006). Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 83, 1432-1446.
88. Viglietta, V., Baecher-Allan, C., Weiner, H.L., and Hafler, D.A. (2004). Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979.
89. Villadangos, J.A. and Young, L. (2008). Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352-361.
90. Wang, Y., Koroleva, E.P., Kruglov, A.A., Kuprash, D.V., Nedospasov, S.A., Fu, Y.X., and Tumanov, A.V. (2010). Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32, 403-413.
91. Waskow, C., Liu, K., Darrasse-Jeze, G., Guermonprez, P., Ginhoux, F., Merad, M., Shengelia, T., Yao, K., and Nussenzweig, M. (2008). The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat. Immunol. 9, 676-683.
92. Wendland, M., Czeloth, N., Mach, N., Malissen, B., Kremmer, E., Pabst, O., and Forster, R. (2007). CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. U S A 104, 6347-6352.
93. Yogev, N., Frommer, F., Lukas, D., Kautz-Neu, K., Karram, K., Ielo, D., von Stebut, E., Probst, H.C., van den Broek, M., Riethmacher, D., et al. (2012). Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 37, 264-275.
94. Young, L.J., Wilson, N.S., Schnorrer, P., Proietto, A., Ten Broeke, T., Matsuki, Y., Mount, A.M., Belz, G.T., O'Keeffe, M., Ohmura-Hoshino, M., et al. (2008). Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat. Immunol. 9, 1244-1252.
95. Zhang, L., Yuan, S., Cheng, G., and Guo, B. (2011). Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 6, e28432.
96. Zozulya, A.L., Clarkson, B.D., Ortler, S., Fabry, Z., and Wiendl, H. (2010). The role of dendritic cells in CNS autoimmunity. J. Mol. Med. (Berl.) 88, 535-544.